Trial Profile
An Open-label, Randomized, Single-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin in Healthy Male Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Amlodipine/losartan (Primary) ; Rosuvastatin
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 21 May 2014 New trial record